The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

How Delaware became a model for improving cancer control, prevention, and treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

As I step down as medical director of the Helen F. Graham Cancer Center and Research Institute (HFGCCRI) at Christiana Care later this year and assume the position of director of the Cawley Center for Translational Cancer Research at the HFGCCRI, I can reflect back on the success of cancer care in Delaware.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Nicholas J. Petrelli, MD
Bank of America Endowed Medical Director, Helen F. Graham Cancer Center and Research Institute, ChristianaCare Health System; Associate director of translational research, Wistar Cancer Institute
Table of Contents

YOU MAY BE INTERESTED IN

Health Equity

Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teams
Why every cancer center needs a Cancer LAW Project

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

By Matthew Bin Han Ong
Health Equity

ACS is using an AI-powered platform in the largest-ever population study of Black women
Time and resources freed up from data management will go to outreach and access

VOICES of Black Women, the largest population study of Black women in the United States, will be the first of American Cancer Society’s large-scale population studies to be initiated using an AI-driven data management platform—promising to bring observational cancer research out of the age of Excel data files and email sharing.
By Jacquelyn Cobb
Byline
Nicholas J. Petrelli, MD
Bank of America Endowed Medical Director, Helen F. Graham Cancer Center and Research Institute, ChristianaCare Health System; Associate director of translational research, Wistar Cancer Institute
Table of Contents

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account